Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.

Area of Science:

• Neuroimmunology
• Psychiatric Research
• Metabolic Pathways

Background:

• The immune system's role in psychiatric disorders is increasingly recognized.
• Lipopolysaccharide (LPS) administration in animal models mimics inflammation and psychiatric symptoms.
• The kynurenine pathway is implicated in LPS-induced behavioral changes, but optimal LPS dosing remains unclear.

Purpose of the Study:

• To investigate the effects of single versus repeated lipopolysaccharide (LPS) administration on the kynurenine pathway.
• To determine the optimal LPS dose and treatment strategy for studying neuroinflammation and psychiatric disorder models.

Main Methods:

• Adult C57BL6 mice received either a single or repeated injection of LPS (0.83 mg/kg).
• Animals were sacrificed at various time points (24, 48, 72, 120 hours) post-injection.
• Brain and serum levels of kynurenine pathway metabolites (kynurenine, kynurenic acid, quinolinic acid) were analyzed.

Main Results:

• Repeated LPS administration significantly elevated brain kynurenine, kynurenic acid, and quinolinic acid levels at 24 and 48 hours.
• Serum kynurenine was elevated at 24, 48, and 72 hours, while serum kynurenic acid decreased at 24 hours post-repeated LPS.
• A single high dose of LPS did not yield similar increases in brain kynurenic acid, suggesting repeated administration is more effective for pathway induction.

Conclusions:

• Repeated LPS administration provides a more robust induction of the kynurenine pathway compared to a single injection.
• These findings offer valuable insights into the kynurenine pathway's role in LPS-induced neuroinflammation and potential psychiatric conditions.
• Understanding optimal LPS treatment strategies is essential for future research on immune system involvement in psychiatric disorders.